Latest News for: passages bios

Edit

Material Event (Form 8-K) (Passage Bio Inc)

Public Technologies 29 Jul 2025
). Item 8.01 Other Events. On July 28, 2025, Passage Bio, Inc ... As a result of this determination, the listing matter is now closed ... Attachments Original document Permalink. Disclaimer. Passage Bio Inc ... (noodl. 125617899) .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Passage Bio Inc)

Public Technologies 25 Jul 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number ... Passage BIO, Inc ... Passage Bio Inc.
Edit

Passage Bio Announces 1-for-20 Reverse Stock Split (Form 8-K) (Passage Bio Inc)

Public Technologies 14 Jul 2025
Passage Bio Announces 1-for-20 Reverse Stock Split. PHILADELPHIA - July 10, 2025 - Passage Bio, Inc. ("Passage Bio" or the "Company") (NASDAQ ... Information for Passage Bio's Stockholders ... About Passage Bio, Inc. Passage Bio (Nasdaq.
Edit

Passage Bio Announces 1-for-20 Reverse Stock Split

The Eagle-Tribune 10 Jul 2025
(“ Passage Bio ” or the “ Company ”) (NASDAQ.
Edit

Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update

Enid News & Eagle 23 Jun 2025
PBFT02 continued to demonstrate robust, durable elevation in CSF PGRN levels and improvement in plasma NfL, a disease progression biomarker, compared to natural history ... .
Edit

PASSAGE BIO REPORTS UPDATED INTERIM DATA FROM UPLIFT-D STUDY AND PROVIDES PROGRAM UPDATE (Form 8-K) (Passage Bio Inc)

Public Technologies 23 Jun 2025
PASSAGE BIO REPORTS UPDATED INTERIM DATA FROM UPLIFT-D STUDY AND PROVIDES PROGRAM UPDATE ... PHILADELPHIA - June 23, 2025 - Passage Bio, Inc ... About Passage Bio. Passage Bio (Nasdaq ... Passage Bio Inc.
Edit

Proxy Results (Form 8-K) (Passage Bio Inc)

Public Technologies 30 May 2025
). Item 5.07. Submission of Matters to a Vote of Security Holders. On May 28, 2025, Passage Bio, Inc ... 1 ... Nominees Shares. For Shares. Withheld Broker. Non-Votes. Maxine Gowen, Ph.D. 26,155,123 9,920,074 13,591,783. Dolan Sondhi, Ph.D ... 2 ... Shares ... 3 ... Passage Bio Inc.
Edit

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights

Nasdaq Globe Newswire 13 May 2025
Treated first FTD-GRN patient with Dose 2 PBFT02 and enrolled second patient; several additional patients being evaluated for trial eligibility ... .
Edit

PASSAGE BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS HIGHLIGHTS (Form 8-K) (Passage Bio Inc)

Public Technologies 13 May 2025
PASSAGE BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS HIGHLIGHTS ... PHILADELPHIA - May 13, 2025 - Passage Bio, Inc ... About Passage Bio. Passage Bio (Nasdaq ... Passage Bio Inc.
Edit

Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q) (Passage Bio Inc)

Public Technologies 13 May 2025
PASSAGE BIO, INC ... Passage Bio, Inc ... Passage Bio, Inc ... Passage Bio, Inc ... Passage Bio, Inc ... Passage Bio, Inc ... Passage Bio, Inc., or the Company, a Delaware corporation incorporated in July 2017, is a clinical ...
  • 1

Article Search

tools
×
×
×
×